研究実績

2023.06.17 論文

論文 2023年

【原著英文2023年】

Yano A, Liu S, Suzuki Y, Imai M, Mogi M, Sugiyama T. Single-cell transcriptomic architecture and cellular communication circuits of parametrial adipose tissue in pregnant mice.
Life Sci. 2023 Dec 1; 334: 122214, doi: 10.1016/j.lfs.2023.122214

Kawasaki M, Arata N, Sugiyama T, Moriya T, Itakura A, Yasuhi I, Uchigata Y, Kawasaki E, Sone H, Hiramatsu Y. Risk of fetal undergrowth in the management of gestational diabetes mellitus in Japan.
J Diabetes Investig. 14:614-622,2023.

Kato H, Saeki N,Imai M, Onji H, Yano A, Yoshida S, Sakaue T, Fujioka T, Sugiyama T, Imai Y. LIM1 contributes to the malignant potential of endometrial cancer.
Front Oncol. 13:1082441,2023

Kubo A, Matsubara K, Matsubara Y, Nakaoka H, Sugiyama T. The Influence of Nicotine on Trophoblast-Derived Exosomes in a Mouse Model of Pathogenic Preeclampsia.
International Journal of Molecular Sciences. 24: 11126,2023

Mukai Y, Kudo Y, Sugiyama T, Kato K. Measures for COVID-19 pregnant women in National University Hospital: 34th National University Perinatal Medical Center Conference.
J Obstet Gynaecol Res. 49:1684-1688,2023

Komine-Aizawa S, Yamada N, Haruyama Y, Deguchi M, Fukuda M, Kawana K, Kobashi G, Miyagi E, Yamada H, Sugiyama T, Hayakawa S. The Factors Influencing Pregnant Women’s Selection of Media Sources to Obtain Information on COVID-19 in Japan in 2021.
Vaccines (Basel). 11:805,2023

Kaneko K, Tsutsumi S, Fujita D, Sugiura-Ogasawara M, Mitsuda N, Matsubara K, Atsumi T, Inoue E, Takimoto T, Murashima A.
Intravenous immunoglobulin treatment for obstetric antiphospholipid syndrome refractory to conventional therapy: a single-arm and open-labelled multicentre clinical trial.
Mod Rheumatol. 2023 345; 3; 515-522. doi: 10.1093/mr/road062.

Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, Nagamatsu T, Takakuwa K, Nakatsuka M, Yoneda S, Egashira K, Tachibana M, Matsubara K, Honda R, Fukui A, Tanaka K, Sengoku K, Endo T, Yata H.
High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
J Reprod Immunol. 2023 Aug:158:103977. doi: 10.1016/j.jri.2023.103977.

【原著和文2023年】

【症例報告和文2023年】

中橋一嘉, 宇佐美知香, 井上 彩,恩地裕史,加藤宏章,安岡稔晃,森本明美,松原裕子,  藤岡 徹, 松原圭一,松元 隆, 杉山 隆. 化学療法抵抗性の難治性絨毛癌に対してPembrolizumabを投与した1例 現代産婦人科、72巻1号 Page13-18 (2023.12)

研究実績一覧へ
TOPへ